Teladoc Health, Inc. (TDOC)
Healthcare
- Fundamental
- 3
- Sentiment
- 2
- Technical
- 1
Do Nothing: qualitativeScore is 2 (below required floor of 3); strategy requires qualitativeScore >= 3 before any bullish entry.
Company overview
Teladoc Health, Inc. provides remote medical services across the United States and internationally, addressing a wide range of health needs including chronic illnesses and mental health issues. The company offers virtual primary and specialized care, chronic disease management, mental wellness support, and expert second opinions under brands like Teladoc, Livongo, and BetterHelp. Founded in 2002 and based in Purchase, New York, Teladoc serves corporations, health insurers, hospitals, and individual patients.
Fundamental
fairTeladoc shows mixed fundamentals with declining revenue and persistent GAAP losses, but positive operating cash flow and manageable leverage.
Mixed fundamentals: revenue has been drifting down and GAAP losses continue, but gross margins are high and operating cash flow has been positive. Liquidity looks adequate (large cash balance plus revolver availability), yet the BetterHelp slowdown and a $1B 2027 convertible maturity keep risk elevated. Low EV/Sales and EV/Adjusted-EBITDA multiples make it a turnaround candidate, not a high-conviction compounder.
Sentiment
weakSentiment is weak following negative Q2 results and guidance reset, with no clear bullish catalyst in the near term.
Dominant near-term driver is a bearish Q2’26 results/guidance-reset narrative (announced 2026-07-29; still digesting), with last ~14d media tone slightly negative and retail signal weak. Baseline sentiment delta is indeterminate (baseline pull timed out), and a moderate red-flag (sharp sentiment deterioration with no near-term bullish catalyst) caps the score at 3; current setup scores 2.
Technical
very weakThe technical setup is bearish, with oversold conditions but no confirmed bullish triggers.
Technical score 1/5: the July 30 earnings gap-down broke TDOC's short-term structure. Price is below SMA20/50/200 and EMA9/21, MACD is negative and below its signal, and ADX 34.27 shows the dominant move is still trend-down. RSI 33.65 and Williams %R -91.67 are oversold, but oversold alone is not a bullish trigger.
You’re looking at 2026-08-06 — about 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.